This article critically examines the substance-based income exclusion (SBIE) under Pillar Two, highlighting its conceptual shortcomings, allocative distortions and bias toward tangible-intensive business models. It argues that the current formula inadequately reflects economic reality and proposes alternative approaches for determining routine returns consistent with modern multinational activities.
Ramon Tomazela (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: